Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:310-315
doi: 10.1161/hy0202.104086
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glueck, S. B.
Right arrow Articles by Dzau, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glueck, S. B.
Right arrow Articles by Dzau, V. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Functional genomics
Right arrow Genetically altered mice
Right arrow Genomics
Right arrow Hypertension - basic studies

(Hypertension. 2002;39:310.)
© 2002 American Heart Association, Inc.


Novartis Lecture

Physiological Genomics: Implications In Hypertension Research

Susan B. Glueck; Victor J. Dzau

From the Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, Mass; and Physiological Genomics, American Physiological Society, Bethesda, Md.

Correspondence to Victor J. Dzau, Brigham and Women’s Hospital, Department of Medicine, 75 Francis Street Suite 230, Boston, MA 02115. E-mail vdzau{at}partners.org

In this article we delineate the directions in which the study of physiology will take as it becomes integrated with genomics. We also provide specific examples of the ways in which physiological genomics may be applied to study the complex genetics of hypertension and cardiovascular disease.


Key Words: genetics • blood pressure • hypertension, essential • hypertension, genetic




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
P. Sinnayah, T. E. Lindley, P. D. Staber, B. L. Davidson, M. D. Cassell, and R. L. Davisson
Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain
Physiol Genomics, June 17, 2004; 18(1): 25 - 32.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. Ueno, J. Tremblay, J. Kunes, J. Zicha, Z. Dobesova, Z. Pausova, A. Y. Deng, Y.-L. Sun, H. J. Jacob, and P. Hamet
Rat model of familial combined hyperlipidemia as a result of comparative mapping
Physiol Genomics, March 12, 2004; 17(1): 38 - 47.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. L. Davisson
Physiological genomic analysis of the brain renin-angiotensin system
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R498 - R511.
[Abstract] [Full Text] [PDF]